Research programme: neural stem cell delivered oncolytic virus - TherabiologicsAlternative Names: TBX.OncV NSCs
Latest Information Update: 16 May 2016
At a glance
- Originator TheraBiologics
- Class Stem cell therapies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Glioma
Most Recent Events
- 16 May 2016 Preclinical trials in Glioma in USA (Intracerebral) before May 2016